A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Saved in:
| Title: | A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma. |
|---|---|
| Authors: | Pu JJ; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States., Berger KN; New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States., Zheng C; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States., Do N; Division of Medicine, VA Boston Healthcare System, Boston, MA, United States.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States., Claxton DF; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Ehmann WC; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Drabick JJ; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States., Li H; Department of Biosystems Engineering, University of Arizona, Tucson, AZ, United States., Loughran TP Jr; Department of Medicine, University of Virginia National Cancer Institute (NCI) Designated Comprehensive Cancer Center, Charlottesville, VA, United States., Epner EM; Penn State Hershey Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Dec 16; Vol. 14, pp. 1449401. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2024.1449401 |
